Form 8-K - Current report:
SEC Accession No. 0001104659-25-062122
Filing Date
2025-06-24
Accepted
2025-06-24 16:30:37
Documents
12
Period of Report
2025-06-24
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518774d1_8k.htm   iXBRL 8-K 25474
  Complete submission text file 0001104659-25-062122.txt   190242

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20250624.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20250624_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20250624_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2518774d1_8k_htm.xml XML 3683
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 251069615
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)